miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.
about
Molecular Mechanisms Underlying Peritoneal EMT and FibrosisMicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeuticsIntegrated miRNA and mRNA Analysis of Time Series Microarray DataThe antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosisRegulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition.A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis.miR-31 is distinctively overexpressed in primary male extramammary Paget's disease.The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary FibrosisInteraction of long noncoding RNAs and microRNAs in the pathogenesis of idiopathic pulmonary fibrosismiR-1343 attenuates pathways of fibrosis by targeting the TGF-β receptors.c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasionThe role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis.Epigenetics in immune-mediated pulmonary diseases.Decreased expression of microRNA-29 family in leiomyoma contributes to increased major fibrillar collagen production.MicroRNA let-7c regulates macrophage polarization.Aging-associated changes in microRNA expression profile of internal anal sphincter smooth muscle: Role of microRNA-133aThe role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
P2860
Q26768501-64F35FCB-5058-4EF6-B5C0-71F9C160D9ACQ28068338-59F5475E-7D57-444E-B706-DA98270C88FFQ28394146-50F216A8-8B61-4E54-B2A3-E47247A984A0Q33724231-090AD36F-24C6-437E-8C54-05CBAAD80E0EQ34979698-C09A8EFE-8936-4016-9798-62E1B1DC73BFQ35605375-F35BE508-4214-4A9E-AC0F-0EA1EBA7FC04Q35970800-EF269E5F-5609-4BD5-BB31-800EED9D89CBQ36059848-654AF192-8B09-42EA-8B85-E9D12F3BA675Q36122861-B9C858E9-3C32-4FB1-9A0F-F8206153179EQ36901906-DEEB94EF-ABA8-4431-875F-BD4ABA5A81E2Q37396605-BB6EAD36-3E27-4139-9568-81AA66DA4D8AQ37591427-21E57E5C-405D-4B53-BC2F-348F6389B321Q38163413-36360BA6-07A8-4B7B-A3E8-4DAE36B3385AQ41013033-697F9706-1BEE-4076-831F-B73FB56E8C20Q41855099-B047E960-10E1-4EBB-8ABB-3999FB28339EQ42499069-3F6B2C6F-CABE-4539-BD9E-E78DA244E03BQ53592908-5C63FDD6-7095-48BE-A153-CD9F87E4848D
P2860
miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.
@ast
miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.
@en
type
label
miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.
@ast
miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.
@en
prefLabel
miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.
@ast
miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.
@en
P2093
P2860
P356
P1433
P1476
miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis
@en
P2093
Edward Abraham
Huachun Cui
Sami Banerjee
Shanzhong Yang
Victor J Thannickal
P2860
P304
P356
10.1096/FJ.11-202366
P407
P50
P577
2012-06-01T00:00:00Z